Evidence map›Paper›PMID 29069790›Full record

ArticleOncotarget2017

Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca

Abdallah Mound, Alexia Vautrin-Glabik, Arthur Foulon, Béatrice Botia, Frédéric Hague, Jan B Parys, Halima Ouadid-Ahidouch, Lise Rodat-Despoix

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Mitochondria-ER crosstalk via MAMS: Bridging cellular homeostasis and cancer progression.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The IPBiochimica et biophysica acta. Molecular basis of disease · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The mitochondrial CabioRxiv : the preprint server for biology · 2023
    Article
  14. The mitochondrial CaFrontiers in cell and developmental biology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abdallah MoundLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Alexia Vautrin-GlabikLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Arthur FoulonLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Béatrice BotiaLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Frédéric HagueLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Jan B ParysLaboratory of Molecular and Cellular Signalling, Department of Cellular and Molecular Medicine, Campus Gasthuisberg O/N1- bus 802-K U Leuven, B-3000 Leuven, Belgium.
Halima Ouadid-AhidouchLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
Lise Rodat-DespoixLaboratory of Cellular and Molecular Physiology (EA-4667), "Ion Channels in Breast Cancer", SFR CAP-SANTE (FED-4231), University of Amiens, UFR Sciences, 80039 Amiens, France.
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains a research priority due to its invasive phenotype. Although the role of ion channels in cancer is now well established, the role of inositol (1,4,5)-trisphosphate (IP

Indexed as

breast cancerCa2+migrationtype 3 inositol 1,4,5-trisphosphate receptor

Identifiers

PMID29069790
PMCPMC5641133
OpenAlexW2745460555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.